Sudarshan Pharma Industries' FCCB Committee has approved the allotment of 48,11,730 fully paid-up equity shares.

These shares, valued at Re.

1/- each, were issued upon the conversion of Foreign Currency Convertible Bonds worth USD 1,500,000. This conversion increases the total issued equity shares to 25,44,70,600, with a paid-up capital of Rs. 25.45 Cr.

This move reflects the conversion of existing debt into equity, impacting the company's capital structure and shareholder base.